September 21, 2015

ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al

Track this case

Case Number:

1:15-cv-07009

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Renee Marie Bumb

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. December 03, 2015

    AstraZeneca Defends NJ Venue In Breast Cancer Drug Row

    AstraZeneca AB blasted Mylan Laboratories Ltd.'s contention that New Jersey is the wrong venue for a patent infringement lawsuit over AstraZeneca's breast cancer drug, arguing Wednesday that it was the generic-drug maker's Garden State subsidiary that filed the application to market its version of the drug.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS